Psychosocial Adaptation to Chronic Illness and Disability: An Updated and Expanded Conceptual Framework
Rehabilitation Counseling Bulletin · 2022-04 · 65 (3) · 171-184
DOI: 10.1177/00343552211034819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rehabilitation Counseling Bulletin, online erschienen am 27.07.2021. Verfasst von Hanoch Livneh. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 107 Literaturangaben.
Abstract (Originalsprache)
The article revisits and updates an earlier model (Livneh, 2001) that examined the building blocks that constitute the dynamics of psychosocial adaptation to chronic illness and disability (CID). In the revised tripartite model, the author reconstructs and refines the earlier model based on recent theoretical formulations, clinical reviews, and research findings. In the revised model, the author discusses three overarching components, namely, antecedents (causes of medical conditions, background variables), processes (the dynamically unfolding course of post-CID events), and outcomes (anticipated exit indicators that serve, as snapshot end products, to assess the individual’s experienced and reported quality of life following onset of CID). The article concludes with a brief review of the model’s practical and research implications.
Zitieren
APA
Livneh, H. (2022). Psychosocial Adaptation to Chronic Illness and Disability: An Updated and Expanded Conceptual Framework. Rehabilitation Counseling Bulletin, 65(3), 171-184. https://doi.org/10.1177/00343552211034819
Vancouver
Livneh H. Psychosocial Adaptation to Chronic Illness and Disability: An Updated and Expanded Conceptual Framework. Rehabilitation Counseling Bulletin. 2022;65(3):171-184. doi:10.1177/00343552211034819
BibTeX
@article{Livneh2022,
author = {Livneh, Hanoch},
title = {Psychosocial Adaptation to Chronic Illness and Disability: An Updated and Expanded Conceptual Framework},
journal = {Rehabilitation Counseling Bulletin},
year = {2022},
volume = {65},
number = {3},
pages = {171--184},
doi = {10.1177/00343552211034819}
}
EUVIMED